Literature DB >> 33378214

How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine.

John J V McMurray1, Milton Packer2,3.   

Abstract

Entities:  

Keywords:  adrenergic beta-antagonists; aldosterone; angiotensin converting enzyme inhibitors; heart failure; neprilysin; receptors, mineralocorticoid; sodium-glucose transport proteins

Mesh：

Substances：

Year:  2020        PMID： 33378214     DOI： 10.1161/CIRCULATIONAHA.120.052926

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  28 in total

1.  Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysis.

Authors:  Yao Neng Teo; Yao Hao Teo; Nicholas L Syn; Celine Shuen Yin Yoong; Alex Jia Yang Cheong; Caitlin Fern Wee; Yoke-Ching Lim; Chi-Hang Lee; Tiong-Cheng Yeo; Ping Chai; Raymond C C Wong; Weiqin Lin; Ching-Hui Sia
Journal:  Clin Drug Investig       Date:  2021-11-19       Impact factor: 2.859

2.  Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategy.

Authors:  Kieran F Docherty; John J V McMurray
Journal:  Br J Cardiol       Date:  2022-01-12

Review 3.  Insights into foundational therapies for heart failure with reduced ejection fraction.

Authors:  John J V McMurray; Kieran F Docherty
Journal:  Clin Cardiol       Date:  2022-06       Impact factor: 3.287

Review 4.  Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?

Authors:  Abhinav Sharma; Subodh Verma; Deepak L Bhatt; Kim A Connelly; Elizabeth Swiggum; Muthiah Vaduganathan; Shelley Zieroth; Javed Butler
Journal:  JACC Basic Transl Sci       Date:  2022-03-02

5.  Capillaries as a Therapeutic Target for Heart Failure.

Authors:  Yohko Yoshida; Ippei Shimizu; Tohru Minamino
Journal:  J Atheroscler Thromb       Date:  2022-04-01       Impact factor: 4.394

Review 6.  Intersection Between Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Luke J Laffin; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

Review 7.  Medical Therapy of Heart Failure with Reduced Ejection Fraction-A Call for Comparative Research.

Authors:  Gad Cotter; Beth A Davison; Alexandre Mebazaa; Koji Takagi; Maria Novosadova; Yonathan Freund; Alain Cohen-Solal
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

Review 8.  Timely and individualized heart failure management: need for implementation into the new guidelines.

Authors:  Amr Abdin; Johann Bauersachs; Norbert Frey; Ingrid Kindermann; Andreas Link; Nikolaus Marx; Mitja Lainscak; Jonathan Slawik; Christian Werner; Jan Wintrich; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2021-05-13       Impact factor: 5.460

9.  Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction.

Authors:  Nicolas Girerd; Jean-Jacques Von Hunolstein; Pierpaolo Pellicori; Antoni Bayés-Genís; Tiny Jaarsma; Lars H Lund; Pascal Bilbault; Jean-Marc Boivin; Tahar Chouihed; Jérôme Costa; Jean-Christophe Eicher; Estelle Fall; David Kenizou; Bruno Maillier; Pierre Nazeyrollas; Gérald Roul; Noura Zannad; Patrick Rossignol; Marie-France Seronde
Journal:  ESC Heart Fail       Date:  2022-04-15

Review 10.  Towards precision medicine in heart failure.

Authors:  Chad S Weldy; Euan A Ashley
Journal:  Nat Rev Cardiol       Date:  2021-06-09       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.